TY - JOUR T1 - Association of Sleep Behaviors with Risk of Esophageal Cancer JF - medRxiv DO - 10.1101/2022.01.23.22269728 SP - 2022.01.23.22269728 AU - Xiaoyan Wang AU - Ruiyi Tian AU - Xiaoyu Zong AU - Myung Sik Jeon AU - Jingqin Luo AU - Graham A. Colditz AU - Jean Wang AU - Konstantinos K. Tsilidis AU - Yo-El S Ju AU - Ramaswamy Govindan AU - Varun Puri AU - Yin Cao Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/24/2022.01.23.22269728.abstract N2 - IMPORTANCE Esophageal cancer is among the most lethal type of cancers worldwide. However, risk factors contributing to more than tenfold increase in esophageal cancer in the last 50 years remain underexplored.OBJECTIVE This study aimed to examine the associations between sleep behaviors and esophageal cancer overall, by histology, and according to genetic predispositions.DESIGN A prospective cohort study.SETTING A population-based study.PARTICIPANTS A total of 410,428 participants aged 37-73 years at enrollment between 2006 and 2010 in the UK Biobank were followed up until March 31st, 2016 for England and Wales and October 31st, 2015 for Scotland.MAIN OUTCOME AND MEASURE The risk of incident esophageal cancer.RESULTS During 2,799,342 person-years of follow-up, 410 incident esophageal cancer cases (294 adenocarcinomas) were diagnosed. Evening chronotype, sleep <6 or >9 h/day, daytime napping, and daytime sleepiness were significantly associated with increased risk of esophageal cancer in age-adjusted models and had a Plikelihood ratio test ≤0.20 after multivariable adjustment. Compared with the group without these high-risk behaviors, participants with one high-risk behavior had a 41% (HR=1.41, 95%CI: 1.13, 1.77) increased risk of esophageal cancer, and those with two or more behaviors showed a 79% higher risk (HR=1.79, 95%CI: 1.32, 2.42) (Ptrend<0.001). These associations were largely driven by esophageal adenocarcinoma (Ptrend<0.001) but not squamous cell carcinoma (Ptrend=0.340). The elevated risks for esophageal adenocarcinoma were similar within strata of PRS quintiles (Pinteraction=0.791).CONCLUSION AND RELEVANCE Unhealthy sleep behaviors were associated with an increased risk of esophageal cancer, primarily adenocarcinoma, independent of genetic risk. Sleep behaviors may serve as modifiable factors for the prevention of esophageal cancer, particularly esophageal adenocarcinomas.Question Are sleep behaviors associated with the risk of esophageal cancer?Findings In this prospective cohort study that included 410,428 participants in the UK Biobank, evening chronotype, sleep <6 or >9 h/day, daytime napping, and sleepiness were associated with increased risk of esophageal cancer. A greater number of these unhealthy sleep behaviors was associated with a higher risk of esophageal cancer. The elevated risks were primarily observed for esophageal adenocarcinoma and were independent of genetic risk.Meaning Sleep behaviors may serve as modifiable factors for the esophageal cancer prevention, particularly esophageal adenocarcinoma, independent of genetic risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by NIH P30CA091842 and Siteman Investment Program to Cao.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from the UK Biobank.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available at UK Biobank. ER -